Currently, the US Preventive Services Task Force recommends routine screening for only four specific cancer types. As a result, most cancers remain undetected until symptoms appear—often at an advanced stage—which places an immense burden on patients, families, and the healthcare system, and contributes to approximately 70% of cancer deaths. This unmet need highlights the urgency for solutions in early cancer screening.
